Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02561455
Title Rollover Study for Subjects Who Have Participated in an Astellas Sponsored ASP2215 Trial
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Astellas Pharma Global Development, Inc.
Indications

Advanced Solid Tumor

acute myeloid leukemia

Therapies

Gilteritinib

Age Groups: adult
Covered Countries USA


No variant requirements are available.